The Latest Cardiac and Vascular News
LAVAL, Québec, Feb. 14, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (HTG) (triglyceride blood levels from 500 mg/dL […]
CEO Shelley Savage will discuss how CardioThrive’s pocket-size automated external defibrillator provides a life-saving shock within the critical first few minutes of an SCA LAGUNA BEACH, Calif.–(BUSINESS WIRE)–Cardiovascular diseases are the No. 1 cause of death worldwide each year. In the U.S. alone, over 1,000 people die of sudden cardiac arrest […]
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world’s most advanced total artificial heart (TAH), aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, announces that the French National Authority for Health (HAS) has deemed the CARMAT TAH eligible with […]
Company builds on its expansion into deeper data analysis and predictive analytics REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k) application for US FDA clearance for its next generation, advanced ECG analysis software. […]
S4 Medical oversubscribes round in preparation for clinical studies COLUMBUS, Ohio, Feb. 13, 2020 /PRNewswire/ — S4 Medical, an innovative medical device company focused on protecting the esophagus from thermal damage during catheter ablation procedures, announced an oversubscribed round of funding following its successful human study. While catheter ablation is an effective […]
VANCOUVER and MINNEAPOLIS, Feb. 12, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE —Neovasc Inc.. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today achievement of design […]
Arrhythmia detection to further expand monitoring options in cardiology community SAN JOSE, Calif., Feb. 12, 2020 /PRNewswire/ — VitalConnect®, Inc., a leader in wearable biosensor technology, announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, Inc., VitalConnect now offers physicians the ability to monitor, diagnose and treat […]
EDEN PRAIRIE, Minn., Feb. 12, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the initiation of distribution agreements covering Germany, Austria and Switzerland with Neucomed Group and its affiliates, further expanding its commercial presence in the European Union. The company now has distribution partnerships covering 13 countries worldwide. […]
Linagliptin did not increase the risk of adverse cardiovascular events, hospitalization for heart failure or adverse kidney events compared with placebo in older people with type 2 diabetes in a prespecified subgroup analysis of the CARMELINA® cardiovascular outcome trial1 In addition, linagliptin did not increase the risk of hypoglycemia compared with […]
PhysIQ receives patent for game-changing deep net approach to estimating functional capacity daily from continuous wearable sensor data. PhysIQ’s adds yet another patent to its extensive portfolio on personalized physiology analytics powered by the similarity-based modeling machine learning approach. CHICAGO–(BUSINESS WIRE)–PhysIQ continues to receive recognition for the novelty and value of […]
